Curating the latest ADC science, clinical data and lessons learned World ADC Berlin will enable you to maximise the clinical therapeutic window of your ADC.
Now in it’s 8th year, World ADC Berlin is Europe’s leading antibody-drug conjugate conference. Across three days, this comprehensive three streamed programme will cover every element of ADCs from discovery, development, manufacturing and clinical.
Attend World ADC Berlin next year to validate novel ADC targets, improve understanding of mechanisms driving toxicity in clinical development and robustly scale up process development to support commercialisation. For 2018, 340 drug developers across 140+ active organisations will unite at this industry focussed conference to foster new connections, further develop business relationships and meet with current partners.
Join your peers at Europe’s longest standing and most comprehensive ADC conference to power the development of your ADC pipeline.
“The World ADC meeting was again a great platform for scientific exchange with networking at its best.” Boehringer Ingelheim
“7th World ADC conference is a perfect platform for budding researchers like me. This meeting is really a golden standard for the current development in the field of ADCs and Immunoncology. I would like to recommend all my colleagues/co-workers to be a part of this event next year” The University of Georgia
“The conference was very well organized and very informative. It brought together researchers across the world who are active in ADC space to share their experiences including successes and failures. Great speed networking events” Pfizer